Description
Active Ingredient: This medicine has active ingredient Lithium Carbonate, which is the carbonate salt of lithium that shows with antimanic and hematopoietic activities. This component acts by interfering with transmembrane sodium exchange in nerve cells. It affects sodium, potassium-stimulated adenosine triphosphatase and altering the release of neurotransmitters. It also affects cyclic adenosine monophosphate concentrations that block inositol metabolism. It is for the depletion of cellular inositol and inhibition of phospholipase C-mediated signal transduction. It exerts its mood-stabilizing effect and stimulates granulocytopoiesis that increases the level of pluripotent hematopoietic stem cells.
Indications: Given effective medication is indicated to treat a manic-depressive disorder or bipolar disorder. Lithium Carbonate composed Eskalith CR tablet stabilizes the mood and reduces the extremes in behavior by restoring the balance of certain natural substances present in the brain.
Action Mechanism: This drug performs its action of the mechanism by stabilizing the mood and reducing the extremes in behavior by restoring the balance of certain natural substances in the brain. This medication has other benefits include it helps decrease the number of manic episodes that occur and decreases the symptoms of manic episodes, like exaggerated feelings of well-being, feelings that other people are trying to harm you, irritability, anxiousness, rapid/loud speech, and aggressive/hostile behaviors.
Dosages: This medication is available in an extended-release tablet for oral consumption. Eskalith CR is made available in a dosage as given below:
- 300 mg: It must be taken 3 to 4 times a day in adults and 2 to 3 times in children as exactly as mentioned in the prescription by the doctor
Note: It is advisable to drink enough water while treating with this medicine. Maintain a healthy diet with normal amounts of salt as directed by the doctor or dietician while taking this medication.
Reviews
There are no reviews yet.